fructose

Fructose is a simple ketose monosaccharide widely found in many plants and commonly combines with glucose to form the disaccharide sucrose. It can be used to induce hyperuricemia and diabetes models.

Fructose-arginine is a non-saponin molecule from Korean Red Ginseng that attenuates AIM2 inflammatory vesicle activation.

D-Fructose (D-arabino-hexulose) , also known as D-(-)-Fructose or D-(-)-Levulose, is classified as a member of the Monosaccharides.

D-fructose-1,6-diphosphate (D-fructose-1,6-diphosphate), also known as Fosfructose, is a cytoprotective natural sugar phosphate. It functions by promoting anaerobic glycolysis, which generates adenosine triphosphate (ATP) under ischemic conditions. This compound holds potential for research in cardiovascular ischemia, sickle cell anemia, and asthma.

D-Fructose-1,6-bisphosphate sodium salt hydrate is the intermediate in carbohydrate metabolism, including glycolysis and gluconeogenesis. During glycolysis, it is produced by phosphorylation of fructose-6-phosphate by phosphofructokinase. The reverse reaction mediated by fructose-1, 6-diphosphatase-1 is one of the rate-limiting steps of gluconeogenesis. The same reaction occurs in the chloroplasts of plants, D-Fructose-1,6-bisphosphate sodium salt hydrate as part of the reducing pentose phosphate cycle. Since cancer cells use glycolysis as a primary source of metabolic energy production, this pathway has become a major target for cancer chemotherapy.

D-Fructose-6-phosphate (sodium salt hydrate) is a sugar intermediate in the glycolytic pathway produced by the isomerization of glucose 6-phosphate by glucose phosphate isomerase, and is used in cancer research.

D-Fructose-13C6 can be used as an internal standard for the quantification of D-fructose by GC- or LC-MS.

D-Fructose-6-phosphate disodium salt (D-FRUCTOSE 6-PHOSPHATE DISODIUM SALT) is an important intermediate in the Carbohydrates pathway. The interconversion of glucose-6-phosphate and fructose-6-phosphate, the second step of the Embden-Meyerhof glycolytic pathway.

Fosfructose trisodium octahydrate is an intermediate in carbohydrate metabolism, participating in glycolysis and gluconeogenesis. It acts as an inhibitor of bacterial acetate kinase and an allosteric activator of PKM2, exhibiting neuroprotective effects.

D-Fructose (Standard) is the analytical standard of D-Fructose, primarily used for quantitative analysis and metabolomics research. D-Fructose is a predominant monosaccharide. Fructose metabolism (fructolysis) is distinct as it bypasses the key rate-limiting step of glycolysis (PFK1), leading to its significant role in lipogenesis and research concerning metabolic disorders.

D-Fructose-13C6 (Standard) is a reference standard of D-Fructose-13C6 intended for quantitative analysis, quality control, and related biochemical research applications. D-Fructose-13C6 can be used as an internal standard for the quantification of D-fructose by GC- or LC-MS.

D-Fructose 6-Phosphate-[13C6] Disodium Salt Hydrate (Standard) is a reference standard of D-Fructose 6-Phosphate-[13C6] Disodium Salt Hydrate intended for quantitative analysis, quality control, and related biochemical research applications.

Sucrose (D-(+)-Saccharose) is a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons.

6-Phosphogluconic acid is a potent and competitive inhibitor of phosphoglucose isomerase (PGI), with an apparent Ki of 0.048 mM for glucose 6-phosphate and 0.042 mM for fructose 6-phosphate as the substrate.

MB-07729 is a potent non-competitive inhibitor of fructose-1,6-bisphosphate with IC50 values of 189, 121 and 31 nM in rat, monkey and human, respectively, for the study of diabetes.

Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes.

Palatinose hydrate (6-O-α-D-Glucopyranosyl-D-fructose, Isoma) is a disaccharide having an α(1→6) linkage between D-glucose and D-fructose and is similar to sucrose in its physicochemical properties. It is produced from sucrose in some bacteria by the action of sucrose isomerase. In mammalian gut, palatinose is hydrolyzed and absorbed much more slowly than sucrose.

Esafosfan trisodium (FDP trisodium) is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia, cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.

Lactulose (Lactulosum) , a synthetic disaccharide , is used in the treatment of constipation and hepatic encephalopathy.

MB05032 is a potent fructose-,-bisphosphatase inhibitor that inhibits gluconeogenesis and reduces d-lactate-triggered ETosis.

FBPase-1 inhibitor-1 (Fructose 1,6-bisphosphatase-1 Inhibitor) is a fructose 1,6-bisphosphatase-1 inhibitor.

Aldolase is a glycolytic enzyme and component of the VATPase complex that catalyzes the reversible cleavage of fructose 1,6-bisphosphate into dihydroxyacetone phosphate and D-glyceraldehyde 3-phosphate. Aldolase plays a critical role in cellular energy metabolism, metabolic flux regulation, and enzymatic studies of glycolysis and related pathways.

Maltulose monohydrate (4-O-α-D-Glucopyranosyl-D-fructose monohydrate) can serve as an energy source for bacteria. It is utilized as a biomaterial or organic compound in life science research.

Fructose-phenylalanine (Fru-Phe) is a non-competitive inhibitor of angiotensin-converting enzyme (ACE) with an IC50 of 0.19 mM, exhibiting antioxidant properties. It forms a stable complex with zinc ions (Zn2+) at the active site of ACE, effectively inhibiting the conversion of angiotensin I to angiotensin II, thereby reducing blood pressure. Fructose-phenylalanine shows potential for research in cardiovascular diseases.